![October 2023 Labs in Court](https://www.g2intelligence.com/wp-content/uploads/2023/09/Oct23.LCA_.LabsInCourt-iStock-61313-1100x800-1-1080x675.jpg)
October 2023 Labs in Court
Recent cases involve charges and judgments related to COVID-19 add-on tests, genetic testing fraud, and kickbacks.
Recent cases involve charges and judgments related to COVID-19 add-on tests, genetic testing fraud, and kickbacks.
In last month’s key cases, Illumina and Guardant seek to dismiss lawsuit related to trade secrets and breach of contract.
More multiplex COVID-19 combination tests emerge from premarket authorization pipeline.
Seven months into the year, there were already four reported deals valued at over $1 billion in 2023, as many as in all of 2022.
An overview of the layoffs announced by major lab diagnostic companies in the first half of 2023 and the key trends.